Here we present the case of an 81-year-old female on ranolazine, diltiazem, and metoprolol who developed profound bradycardia (atrial fibrillation with slowed ventricular response) and hypotension due to reduced clearance of these drugs from CYP inhibition. The gene discussed is PPIG; the disease is atrial fibrillation.